ymjЯкутский медицинский журналYakut Medical Journal1813-19052312-1017ЯНЦ КМП10.25789/YMJ.2026.94.20ymj-3341Research ArticleНАУЧНЫЕ ОБЗОРЫSCIENTIFIC REVIEWSСовременные научные представления об оспе обезьян: обзор актуальных исследованийCurrent scientific perspectives on Mpox: a review of recent research and literature datahttps://orcid.org/0000-0002-2175-5547МельниковВ. Л.MelnikovV. L.

Мельников Виктор Львович ‒ д-р мед. наук, зав. кафедрой «Микробиология, эпидемиология и инфекционные болезни».

ул. Красная, д. 40, Пенза, 440026

https://orcid.org/0000-0003-4308-9597АфтаеваЛ. Н.AftaevaL. N.

Афтаева Лариса Николаевна ‒ канд. мед. наук, доц. кафедры «Микробиология, эпидемиология и инфекционные болезни».

ул. Красная, д. 40, Пенза, 440026

l.aftaeva@mail.ruhttps://orcid.org/0009-0004-9430-4263СергееваА. В.SergeevaA. V.

Сергеева Анастасия Валерьевна ‒ студент.

ул. Красная, д. 40, Пенза, 440026

https://orcid.org/0009-0005-1557-1046БезменоваД. С.BezmenovaD. S.

Безменова Дарья Сергеевна ‒ студент.

ул. Красная, д. 40, Пенза, 440026

bezmenova.02@gmail.comhttps://orcid.org/0009-0008-1228-3139ЛебедеваО. С.LebedevaO. S.

Лебедева Олеся Сергеевна ‒ студент.

ул. Красная, д. 40, Пенза, 440026

ФГБОУ ВО «Пензенский государственный университет»Russian Federation202621062026028691Copyright © Мельников В.Л., Афтаева Л.Н., Сергеева А.В., Безменова Д.С., Лебедева О.С., 20262026Мельников В.Л., Афтаева Л.Н., Сергеева А.В., Безменова Д.С., Лебедева О.С.Melnikov V.L., Aftaeva L.N., Sergeeva A.V., Bezmenova D.S., Lebedeva O.S.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://ymj.elpub.ru/jour/article/view/3341

В обзорной статье представлены эпидемиологические, этиопатогенетические, клинические, диагностические аспекты оспы обезьян (MPOX), а также рассмотрены возможные меры профилактики и лечения данного инфекционного заболевания. Возбудитель – вирус оспы обезьян (MPXV) – передается различными путями: половым, контактно-бытовым, воздушно-капельным, что определяет особенности клинической картины пациентов, высокий процент летальности. На сегодняшний день применяется ограниченное количество лекарственных препаратов, оказывающих воздействие на вирусы семейства Poxviridae. Поэтому MPXV сохраняет статус приоритетного объекта для исследований в рамках вирусологии и эпидемиологии.

The review article presents the epidemiological, etiopathogenetic, clinical, and diagnostic aspects of monkeypox (MPOX), as well as possible measures for the prevention and treatment of this infectious disease. The causative agent, the monkeypox virus (MPXV), is transmitted in various ways: sexually, through household contact, and airborne droplets, which determines the clinical features of patients and a high mortality rate. Currently, a limited number of drugs are used that affect viruses of the Poxviridae family. Therefore, MPXV retains the status of a priority object for research in virology and epidemiology.

оспа обезьянвирус оспы обезьянMPXVклада вирусакожные высыпанияДНК-вирусmonkeypoxmonkeypox virusMPXVvirus cladeskin rashesDNA virusReferencesGhosh N., Chacko L., Vallamkondu J., et al. Clinical Strategies and Therapeutics for Human Monkeypox Virus: A Revised Perspective on Recent Outbreaks. Viruses. 2023; 15(7):1533. DOI: 10.3390/v15071533.Ghosh N., Chacko L., Vallamkondu J., et al. Clinical Strategies and Therapeutics for Human Monkeypox Virus: A Revised Perspective on Recent Outbreaks. Viruses. 2023; 15(7):1533. DOI: 10.3390/v15071533.СП 3.3686-21 «Санитарно-эпидемиологические требования по профилактике инфекционных болезней». Приложение 1. Классификация микроорганизмов — возбудителей инфекционных болезней по группам патогенности. Утверждены постановлением Главного государственного санитарного врача РФ от 28.01.2021 №4SP 3.3686-21 "Sanitary and epidemiological requirements for the prevention of infectious diseases". Appendix 1. Classification of microorganisms — causative agents of infectious diseases by pathogenicity groups. Approved by Resolution No. 4 of the Chief State Sanitary Doctor of the Russian Federation dated January 28, 2021 (In Russian).Bunge E.M., Hoet B., Chen L., et al. The changing epidemiology of human monkeypox – A potential threat? A systematic review. PLoS Negl Trop Dis. 2022; 16(2):e0010141. PMID: 35148313.Bunge E.M., Hoet B., Chen L., et al. The changing epidemiology of human monkeypox – A potential threat? A systematic review. PLoS Negl Trop Dis. 2022; 16(2):e0010141. PMID: 35148313.Alakunle E., Kolawole D., Diaz-Cánova D., et al. A comprehensive review of monkeypox virus and mpox characteristics. Front Cell Infect Microbiol. 2024; 14:1360586. DOI: 10.3389/fcimb.2024.1360586Alakunle E., Kolawole D., Diaz-Cánova D., et al. A comprehensive review of monkeypox virus and mpox characteristics. Front Cell Infect Microbiol. 2024; 14:1360586. DOI: 10.3389/fcimb.2024.1360586Rabaan A.A., Alasiri N.A., Aljeldah M., et al. An Updated Review on Monkeypox Viral Disease: Emphasis on Genomic Diversity. Biomedicines. 2023; 11(7):1832. DOI: 10.3390/biomedicines11071832Rabaan A.A., Alasiri N.A., Aljeldah M., et al. An Updated Review on Monkeypox Viral Disease: Emphasis on Genomic Diversity. Biomedicines. 2023; 11(7):1832. DOI: 10.3390/biomedicines11071832Malik S., Ahmed A., Ahsan O., et al. Monkeypox Virus: A Comprehensive Overview of Viral Pathology, Immune Response, and Antiviral Strategies. Vaccines (Basel). 2023; 11(8):1345. Published 2023 DOI:10.3390/vaccines11081345Malik S., Ahmed A., Ahsan O., et al. Monkeypox Virus: A Comprehensive Overview of Viral Pathology, Immune Response, and Antiviral Strategies. Vaccines (Basel). 2023; 11(8):1345. Published 2023 DOI:10.3390/vaccines11081345Sagdat K., Batyrkhan A., Kanayeva D. Exploring monkeypox virus proteins and rapid detection techniques. Front Cell Infect Microbiol. 2024; 14:1414224. DOI: 10.3389/fcimb.2024.1414224Sagdat K., Batyrkhan A., Kanayeva D. Exploring monkeypox virus proteins and rapid detection techniques. Front Cell Infect Microbiol. 2024; 14:1414224. DOI: 10.3389/fcimb.2024.1414224McInnes C.J., Damon I.K., Smith G.L., et al. ICTV Virus Taxonomy Profile: Poxviridae 2023. J Gen Virol. 2023; 104(5). DOI: 10.1099/jgv.0.001849.McInnes C.J., Damon I.K., Smith G.L., et al. ICTV Virus Taxonomy Profile: Poxviridae 2023. J Gen Virol. 2023; 104(5). DOI: 10.1099/jgv.0.001849.Esteban D.J., Hutchinson A.P. Genes in the terminal regions of orthopoxvirus genomes experience adaptive molecular evolution. BMC Genomics. 2011; 12: 261. DOI: 10.1186/1471-2164-12-261Esteban D.J., Hutchinson A.P. Genes in the terminal regions of orthopoxvirus genomes experience adaptive molecular evolution. BMC Genomics. 2011; 12: 261. DOI: 10.1186/1471-2164-12-261Rampogu S., Kim Y., Kim SW., et al. An overview on monkeypox virus: Pathogenesis, transmission, host interaction and therapeutics. Front Cell Infect Microbiol. 2023; 13:1076251. DOI:10.3389/fcimb.2023.1076251Rampogu S., Kim Y., Kim SW., et al. An overview on monkeypox virus: Pathogenesis, transmission, host interaction and therapeutics. Front Cell Infect Microbiol. 2023; 13:1076251. DOI:10.3389/fcimb.2023.1076251Silhan J., Klima M., Otava T., et al. Discovery and structural characterization of monkeypox virus methyltransferase VP39 inhibitors reveal similarities to SARS-CoV-2 nsp14 methyltransferase. Nat Commun. 2023; 14(1): 2259. DOI:10.1038/s41467-023-38019-1Silhan J., Klima M., Otava T., et al. Discovery and structural characterization of monkeypox virus methyltransferase VP39 inhibitors reveal similarities to SARS-CoV-2 nsp14 methyltransferase. Nat Commun. 2023; 14(1): 2259. DOI:10.1038/s41467-023-38019-1Ogoina D., Dalhat M.M., Denue B.A., et al. Mpox Epidemiology and Risk Factors, Nigeria, 2022. Emerg Infect Dis. 2024; 30(9): 1799-1808. DOI:10.3201/eid3009.240135Ogoina D., Dalhat M.M., Denue B.A., et al. Mpox Epidemiology and Risk Factors, Nigeria, 2022. Emerg Infect Dis. 2024; 30(9): 1799-1808. DOI:10.3201/eid3009.240135Sun J., Zhou L., Wu B. et al. Characteristics of the first confirmed case of human infection with mpox virus clade Ib in China. Nat Commun 2025; 16: 4888. DOI: 10.1038/s41467-025-60217-2Sun J., Zhou L., Wu B. et al. Characteristics of the first confirmed case of human infection with mpox virus clade Ib in China. Nat Commun 2025; 16: 4888. DOI: 10.1038/s41467-025-60217-2Krishna S., Kurrey C., Yadav M., et al. Insights into the emergence and evolution of monkeypox virus: Historical perspectives, epidemiology, genetic diversity, transmission, and preventative measures. Infect Med (Beijing). 2024; 3(2): 100105. DOI:10.1016/j.imj.2024.100105Krishna S., Kurrey C., Yadav M., et al. Insights into the emergence and evolution of monkeypox virus: Historical perspectives, epidemiology, genetic diversity, transmission, and preventative measures. Infect Med (Beijing). 2024; 3(2): 100105. DOI:10.1016/j.imj.2024.100105Elizabeth A. Falendysz, Juan G. Lopera, Tonie E. Rocke and Jorge E. Osorio. Monkeypox Virus in Animals: Current Knowledge of Viral Transmission and Pathogenesis in Wild Animal Reservoirs and Captive Animal Models. Viruses. 2023; 15(4): 905. DOI: 10.3390/v15040905Elizabeth A. Falendysz, Juan G. Lopera, Tonie E. Rocke and Jorge E. Osorio. Monkeypox Virus in Animals: Current Knowledge of Viral Transmission and Pathogenesis in Wild Animal Reservoirs and Captive Animal Models. Viruses. 2023; 15(4): 905. DOI: 10.3390/v15040905Ullah M., Li Y., Munib K., et al. Epidemiology, host range, and associated risk factors of monkeypox: an emerging global public health threat. Front Microbiol. 2023; 14:1160984. DOI:10.3389/fmicb.2023.1160984Ullah M., Li Y., Munib K., et al. Epidemiology, host range, and associated risk factors of monkeypox: an emerging global public health threat. Front Microbiol. 2023; 14:1160984. DOI:10.3389/fmicb.2023.1160984Thakur M., Das P., Sobti R.C., et al. Human monkeypox: epidemiology, transmission, pathogenesis, immunology, diagnosis and therapeutics. Mol Cell Biochem. 2023; 478(9): 2097-2110. DOI:10.1007/s11010-022-04657-0Thakur M., Das P., Sobti R.C., et al. Human monkeypox: epidemiology, transmission, pathogenesis, immunology, diagnosis and therapeutics. Mol Cell Biochem. 2023; 478(9): 2097-2110. DOI:10.1007/s11010-022-04657-0Ogoina D., Ogunsola F.T. Monkeypox and the health-care environment. Lancet Microbe. 2022; 3(12): e889-e890. DOI:10.1016/S2666-5247(22)00286-5Ogoina D., Ogunsola F.T. Monkeypox and the health-care environment. Lancet Microbe. 2022; 3(12): e889-e890. DOI:10.1016/S2666-5247(22)00286-5Kumar A., Singh N., Anvikar A.R., et al. Monkeypox virus: insights into pathogenesis and laboratory testing methods. 3 Biotech. 2024;14(3):67. DOI: 10.1007/s13205-024-03920-zKumar A., Singh N., Anvikar A.R., et al. Monkeypox virus: insights into pathogenesis and laboratory testing methods. 3 Biotech. 2024;14(3):67. DOI: 10.1007/s13205-024-03920-zLum F.M., Torres-Ruesta A., Tay M.Z., et al. Monkeypox: disease epidemiology, host immunity and clinical interventions. Nat Rev Immunol. 2022;22(10):597-613. DOI:10.1038/s41577-022-00775-4Lum F.M., Torres-Ruesta A., Tay M.Z., et al. Monkeypox: disease epidemiology, host immunity and clinical interventions. Nat Rev Immunol. 2022;22(10):597-613. DOI:10.1038/s41577-022-00775-4Simoes P., Bhagani S. A viewpoint: The 2022 monkeypox outbreak. J Virus Erad. 2022;8(2):100078. DOI:10.1016/j.jve.2022.100078Simoes P., Bhagani S. A viewpoint: The 2022 monkeypox outbreak. J Virus Erad. 2022;8(2):100078. DOI:10.1016/j.jve.2022.100078Niu L., Liang D., Ling Q., et al. Insights into monkeypox pathophysiology, global prevalence, clinical manifestation and treatments. Front Immunol. 2023;14:1132250. DOI:10.3389/fimmu.2023.1132250Niu L., Liang D., Ling Q., et al. Insights into monkeypox pathophysiology, global prevalence, clinical manifestation and treatments. Front Immunol. 2023;14:1132250. DOI:10.3389/fimmu.2023.1132250Rampogu S., Kim Y., Kim S.W., et al. An overview on monkeypox virus: Pathogenesis, transmission, host interaction and therapeutics. Front Cell Infect Microbiol. 2023;13:1076251. Doi: 10.3389/fcimb.2023.1076251Rampogu S., Kim Y., Kim S.W., et al. An overview on monkeypox virus: Pathogenesis, transmission, host interaction and therapeutics. Front Cell Infect Microbiol. 2023;13:1076251. Doi: 10.3389/fcimb.2023.1076251Alakunle E., Kolawole D., Diaz-Cánova D., et al. A comprehensive review of monkeypox virus and mpox characteristics. Front Cell Infect Microbiol. 2024;14:1360586. DOI:10.3389/fcimb.2024.1360586Alakunle E., Kolawole D., Diaz-Cánova D., et al. A comprehensive review of monkeypox virus and mpox characteristics. Front Cell Infect Microbiol. 2024;14:1360586. DOI:10.3389/fcimb.2024.1360586Parnian R., Heydarifard F., Mousavi F.S., et al. Innate Immune Response to Monkeypox Virus Infection: Mechanisms and Immune Escape. J Innate Immun. 2024;16(1):413-424. DOI:10.1159/000540815Parnian R., Heydarifard F., Mousavi F.S., et al. Innate Immune Response to Monkeypox Virus Infection: Mechanisms and Immune Escape. J Innate Immun. 2024;16(1):413-424. DOI:10.1159/000540815Pishesha N., Harmand T.J., Ploegh H.L. A guide to antigen processing and presentation. Nat Rev Immunol. 2022;22(12):751-764. DOI:10.1038/s41577-022-00707-2Pishesha N., Harmand T.J., Ploegh H.L. A guide to antigen processing and presentation. Nat Rev Immunol. 2022;22(12):751-764. DOI:10.1038/s41577-022-00707-2da Silva G.B., de Carvalho Braga G., Simões J.L.B., et al. Cytokine storm in human monkeypox: A possible involvement of purinergic signaling. Cytokine. 2024;177:156560. DOI:10.1016/j.cyto.2024.156560da Silva G.B., de Carvalho Braga G., Simões J.L.B., et al. Cytokine storm in human monkeypox: A possible involvement of purinergic signaling. Cytokine. 2024;177:156560. DOI:10.1016/j.cyto.2024.156560Sharma R., Chen K.T., Sharma R. Emerging evidence on Monkeypox: resurgence, global burden, molecular insights, genomics and possible management. Front Cell Infect Microbiol. 2023;13:1134712. DOI:10.3389/fcimb.2023.1134712Sharma R., Chen K.T., Sharma R. Emerging evidence on Monkeypox: resurgence, global burden, molecular insights, genomics and possible management. Front Cell Infect Microbiol. 2023;13:1134712. DOI:10.3389/fcimb.2023.1134712Khattak S., Rauf M.A., Ali Y., et al. The monkeypox diagnosis, treatments and prevention: A review. Front Cell Infect Microbiol. 2023;12:1088471. DOI:10.3389/fcimb.2022.1088471Khattak S., Rauf M.A., Ali Y., et al. The monkeypox diagnosis, treatments and prevention: A review. Front Cell Infect Microbiol. 2023;12:1088471. DOI:10.3389/fcimb.2022.1088471Martinez-Fernandez D.E., Fernandez-Quezada D., Casillas-Muñoz F.A.G., et al. Human Monkeypox: A Comprehensive Overview of Epidemiology, Pathogenesis, Diagnosis, Treatment, and Prevention Strategies. Pathogens. 2023;12(7):947. DOI:10.3390/pathogens12070947Martinez-Fernandez D.E., Fernandez-Quezada D., Casillas-Muñoz F.A.G., et al. Human Monkeypox: A Comprehensive Overview of Epidemiology, Pathogenesis, Diagnosis, Treatment, and Prevention Strategies. Pathogens. 2023;12(7):947. DOI:10.3390/pathogens12070947Angelo K.M., Smith T., Camprubi-Ferrer D., et al. Epidemiological and clinical characteristics of patients with monkeypox in the GeoSentinel Network: a cross-sectional study. Lancet Infect Dis. 2023;23(2):196-206. DOI:10.1016Angelo K.M., Smith T., Camprubi-Ferrer D., et al. Epidemiological and clinical characteristics of patients with monkeypox in the GeoSentinel Network: a cross-sectional study. Lancet Infect Dis. 2023;23(2):196-206. DOI:10.1016Silva S.J.R.D., Kohl A., Pena L., et al. Clinical and laboratory diagnosis of monkeypox (mpox): Current status and future directions. iScience. 2023;26(6):106759. DOI:10.1016/j.isci.2023.106759Silva S.J.R.D., Kohl A., Pena L., et al. Clinical and laboratory diagnosis of monkeypox (mpox): Current status and future directions. iScience. 2023;26(6):106759. DOI:10.1016/j.isci.2023.106759Ahmed S.K., Ahmed Rashad E.A., Mohamed M.G., et al. The global human monkeypox outbreak in 2022: An overview. Int J Surg. 2022;104:106794. DOI:10.1016/j.ijsu.2022.106794Ahmed S.K., Ahmed Rashad E.A., Mohamed M.G., et al. The global human monkeypox outbreak in 2022: An overview. Int J Surg. 2022;104:106794. DOI:10.1016/j.ijsu.2022.106794McLean J., Gunaratne S., Zucker J. Update on Mpox: What the Primary Care Clinician Should Know. Med Clin North Am. 2024;108(2):355-371. DOI:10.1016/j.mcna.2023.09.005McLean J., Gunaratne S., Zucker J. Update on Mpox: What the Primary Care Clinician Should Know. Med Clin North Am. 2024;108(2):355-371. DOI:10.1016/j.mcna.2023.09.005Guevara-Martinez J., La-Noire F.P., Arteaga-Asensio P., et al. Proctitis in patients with monkeypox infection: a single-center analysis of 42 consecutive cases from a multidisciplinary observational study on monkeypox proctitis. Tech Coloproctol. 2023;27(12):1211-1218. DOI:10.1007/s10151-023-02782-6Guevara-Martinez J., La-Noire F.P., Arteaga-Asensio P., et al. Proctitis in patients with monkeypox infection: a single-center analysis of 42 consecutive cases from a multidisciplinary observational study on monkeypox proctitis. Tech Coloproctol. 2023;27(12):1211-1218. DOI:10.1007/s10151-023-02782-6Li Y., Zhao H., Wilkins K., et al. Real-time PCR assays for the specific detection of monkeypox virus West African and Congo Basin strain DNA. J Virol Methods. 2022;169(1):223-227. DOI:10.1016/j.jviromet.2010.07.012Li Y., Zhao H., Wilkins K., et al. Real-time PCR assays for the specific detection of monkeypox virus West African and Congo Basin strain DNA. J Virol Methods. 2022;169(1):223-227. DOI:10.1016/j.jviromet.2010.07.012Shchelkunova G.A., Shchelkunov S.N. Smallpox, Monkeypox and Other Human Orthopoxvirus Infections. Viruses. 2022;15(1):103. DOI:10.3390/v15010103Shchelkunova G.A., Shchelkunov S.N. Smallpox, Monkeypox and Other Human Orthopoxvirus Infections. Viruses. 2022;15(1):103. DOI:10.3390/v15010103De Pace V., Bruzzone B., Ricucci V., et al. Molecular Diagnosis of Human Monkeypox Virus during 2022-23 Outbreak: Preliminary Evaluation of Novel Real-Time Qualitative PCR Assays. Microorganisms. 2024;12(4):664. DOI:10.3390/microorganisms12040664De Pace V., Bruzzone B., Ricucci V., et al. Molecular Diagnosis of Human Monkeypox Virus during 2022-23 Outbreak: Preliminary Evaluation of Novel Real-Time Qualitative PCR Assays. Microorganisms. 2024;12(4):664. DOI:10.3390/microorganisms12040664Michel J., Targosz A., Rinner T., et al. Evaluation of 11 commercially available PCR kits for the detection of monkeypox virus DNA, Berlin, July to September 2022. Euro Surveill. 2022;27(45):2200816. DOI:10.2807/1560-7917.ES.2022.27.45.2200816Michel J., Targosz A., Rinner T., et al. Evaluation of 11 commercially available PCR kits for the detection of monkeypox virus DNA, Berlin, July to September 2022. Euro Surveill. 2022;27(45):2200816. DOI:10.2807/1560-7917.ES.2022.27.45.2200816Anderson M., Hodges A., Luk K.C., et al. Development and Validation of Three Automated High-Throughput Molecular Tests to Detect Monkeypox Virus Infections. J Infect Dis. 2024;229(Supplement_2):S137-S143. DOI:10.1093/infdis/jiad406Anderson M., Hodges A., Luk K.C., et al. Development and Validation of Three Automated High-Throughput Molecular Tests to Detect Monkeypox Virus Infections. J Infect Dis. 2024;229(Supplement_2):S137-S143. DOI:10.1093/infdis/jiad406Kim B., Karlin K.D. Ligand-Copper(I) Primary O2-Adducts: Design, Characterization, and Biological Significance of Cupric-Superoxides. Acc Chem Res. 2023;56(16):2197-2212. DOI:10.1021/acs.accounts.3c00297Kim B., Karlin K.D. Ligand-Copper(I) Primary O2-Adducts: Design, Characterization, and Biological Significance of Cupric-Superoxides. Acc Chem Res. 2023;56(16):2197-2212. DOI:10.1021/acs.accounts.3c00297Hraib M., Jouni S., Albitar M.M., et al. The outbreak of monkeypox 2022: An overview. Ann Med Surg (Lond). 2022;79:104069. DOI:10.1016/j.amsu.2022.104069Hraib M., Jouni S., Albitar M.M., et al. The outbreak of monkeypox 2022: An overview. Ann Med Surg (Lond). 2022;79:104069. DOI:10.1016/j.amsu.2022.104069Imran M., Alshammari M.K., Arora MK., et al. Oral Brincidofovir Therapy for Monkeypox Outbreak: A Focused Review on the Therapeutic Potential, Clinical Studies, Patent Literature, and Prospects. Biomedicines. 2023;11(2):278. DOI:10.3390/biomedicines11020278Imran M., Alshammari M.K., Arora MK., et al. Oral Brincidofovir Therapy for Monkeypox Outbreak: A Focused Review on the Therapeutic Potential, Clinical Studies, Patent Literature, and Prospects. Biomedicines. 2023;11(2):278. DOI:10.3390/biomedicines11020278Hoy S.M. Tecovirimat: First Global Approval. Drugs. 2018;78(13):1377-1382. DOI:10.1007/s40265-018-0967-6Hoy S.M. Tecovirimat: First Global Approval. Drugs. 2018;78(13):1377-1382. DOI:10.1007/s40265-018-0967-6Шишкина Л.Н., Богрянцева М.П., Бормотов Н.И. и др. Безопасность нового российского противооспенного препарата НИОХ-14: открытое рандомизированное клиническое исследование I фазы. Безопасность и риск фармакотерапии. 2025;13(1):20-30. DOI: 10.30895/2312-7821-2025-467Shishkina L.N., Bogryantseva M.P., Bormotov N.I. and others. Safety of the new Russian anti-inflammatory drug NIOH-14: an open randomized phase I clinical trial. Safety and risk of pharmacotherapy. 2025;13(1):20-30 (In Russian). DOI: 10.30895/2312-7821-2025-467Zhu W., Zhang M., Zhang M., et al. The Generation and Characterization of Monoclonal Antibodies against the MPXV A29L Protein. Viruses. 2024;16(8):1184. DOI:10.3390/v16081184Zhu W., Zhang M., Zhang M., et al. The Generation and Characterization of Monoclonal Antibodies against the MPXV A29L Protein. Viruses. 2024;16(8):1184. DOI:10.3390/v16081184Melendez J.A., Sun H., Bonner J., et al. Characterization of a plant-derived monoclonal antibody targeting extracellular enveloped virions of Monkeypox virus. Front Plant Sci. 2024;15:1481452. DOI:10.3389/fpls.2024.1481452Melendez J.A., Sun H., Bonner J., et al. Characterization of a plant-derived monoclonal antibody targeting extracellular enveloped virions of Monkeypox virus. Front Plant Sci. 2024;15:1481452. DOI:10.3389/fpls.2024.1481452Maredia H., Sartori-Valinotti J. C., Ranganath N., et al. Supportive Care Management Recommendations for Mucocutaneous Manifestations of Monkeypox Infection. Mayo Clinic proceedings. 2023; 98(6), 828–832. doi:10.1016/j.mayocp.2023.01.019Maredia H., Sartori-Valinotti J. C., Ranganath N., et al. Supportive Care Management Recommendations for Mucocutaneous Manifestations of Monkeypox Infection. Mayo Clinic proceedings. 2023; 98(6), 828–832. doi:10.1016/j.mayocp.2023.01.019Sulaiman S.K., Isma'il Tsiga-Ahmed F., Musa M.S., et al. Global prevalence and correlates of mpox vaccine acceptance and uptake: a systematic review and meta-analysis. Commun Med (Lond). 2024;4(1):136. DOI:10.1038/s43856-024-00564-1Sulaiman S.K., Isma'il Tsiga-Ahmed F., Musa M.S., et al. Global prevalence and correlates of mpox vaccine acceptance and uptake: a systematic review and meta-analysis. Commun Med (Lond). 2024;4(1):136. DOI:10.1038/s43856-024-00564-1Wang Y. Rendezvous with Vaccinia in the Post-smallpox Era: R&D Advances. Viruses. 2023;15(8):1742. DOI: 10.3390/v15081742Wang Y. Rendezvous with Vaccinia in the Post-smallpox Era: R&D Advances. Viruses. 2023;15(8):1742. DOI: 10.3390/v15081742Борисевич С.В., Подкуйко В.Н., Пирожков А.П. и др. Эволюция средств и принципов оспопрививания. Вестник войск РХБ защиты. 2020;4(1):66-85. DOI:10.35825/2587-5728-2020-4-1-66-85Borisevich S.V., Podkuiko V.N., Pirozhkov A.P. and others. Evolution of the means and principles of vaccination. Bulletin of the RCB Protection troops. 2020; 4(1):66-85 (In Russian). DOI:10.35825/2587-5728-2020-4-1-66-85Jacob-Dolan C., Ty D., Hope D., et al. Comparison of the immunogenicity and protective efficacy of ACAM2000, MVA, and vectored subunit vaccines for Mpox in rhesus macaques. Sci Transl Med. 2024;16(740):eadl4317. DOI:10.1126/scitranslmed.adl4317Jacob-Dolan C., Ty D., Hope D., et al. Comparison of the immunogenicity and protective efficacy of ACAM2000, MVA, and vectored subunit vaccines for Mpox in rhesus macaques. Sci Transl Med. 2024;16(740):eadl4317. DOI:10.1126/scitranslmed.adl4317WHO adds LC16m8 mpox vaccine to Emergency Use Listing. Saudi Med J. 2024;45(12):1401-1402. PMID: 39658109WHO adds LC16m8 mpox vaccine to Emergency Use Listing. Saudi Med J. 2024;45(12):1401-1402. PMID: 39658109Перекрест В.В., Мовсесянц А.А., Мухачева А.В. и др. «Препараты для специфической профилактики натуральной оспы, зарегистрированные в Российской Федерации» БИО-препараты. Профилактика, диагностика, лечение. 2 (46), 2013. DOI:10.35825/2587-5728-2020-4-1-66-85Perekrest V.V., Movsesyants A.A., Mukhacheva A.V. and others. "Preparations for the specific prevention of smallpox registered in the Russian Federation" Biologics. Prevention, diagnosis, and treatment. 2 (46), 2013 (In Russian). DOI:10.35825/2587-5728-2020-4-1-66-85.

The authors declare that there are no conflicts of interest present.